BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 09-Jun-2020

(Q3 Un-audited): Consolidated EPS was Tk. 4.28 for January-March 2020 as against Tk. 3.69 for January-March 2019; Consolidated EPS was Tk. 12.44 for July 2019-March 2020 as against Tk. 11.15 for July 2018-March 2019. Consolidated NOCFPS was Tk. 10.13 for July 2019-March 2020 as against Tk. 10.57 for July 2018-March 2019. Consolidated NAV per share was Tk. 88.19 as on March 31, 2020 and Tk. 80.40 as on June 30, 2019.

SQURPHARMA 01-Jun-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 08, 2020 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

SQURPHARMA 29-Apr-2019

(Q3 Un-audited): Consolidated EPS was Tk. 3.95 for January-March 2019 as against Tk. 3.77 for January-March 2018; Consolidated EPS was Tk. 11.93 for July 2018-March 2019 as against Tk. 11.20 for July 2017-March 2018. Consolidated NOCFPS was Tk. 11.34 for July 2018-March 2019 as against Tk. 10.52 for July 2017-March 2018. Consolidated NAV per share was Tk. 81.95 as on March 31, 2019 and Tk. 73.28 as on June 30, 2018.

SQURPHARMA 23-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2019 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

SQURPHARMA 30-Apr-2018

(Q3 Un-audited): Consolidated EPS was Tk. 4.04 for January-March 2018 as against Tk. 3.98 for January-March 2017; Consolidated EPS was Tk. 11.99 for July 2017-March 2018 as against Tk. 10.59 for July 2016-March 2017. Consolidated NOCFPS was Tk. 11.26 for July 2017-March 2018 as against Tk. 11.49 for July 2016-March 2017. Consolidated NAV per share was Tk. 74.75 as on March 31, 2018 and Tk. 66.49 as on June 30, 2017.

SQURPHARMA 23-Apr-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2018 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2018.

SQURPHARMA 02-May-2017

(Q3 Un-audited): Consolidated EPS was Tk. 4.27 for January-March 2017 as against Tk. 3.64 for January-March 2016; Consolidated EPS was Tk. 11.39 for July 2016-March 2017 as against Tk. 9.74 for July'15-March'16. Consolidated NOCFPS was Tk. 12.35 for July 2016-March 2017 as against Tk. 12.08 for July 2015-March 2016. Consolidated NAV per share was Tk. 67.51 as of March 31, 2017 and Tk. 59.13 as of June 30, 2016.

SQURPHARMA 25-Apr-2017

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2017 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

SQURPHARMA 31-Jan-2016

(Q3 Un-audited): Consolidated EPS was Tk. 3.39 for October-December, 2015 as against Tk. 2.45 for October-December, 2014; Consolidated EPS was Tk. 9.48 for April-December, 2015 as against Tk. 6.77 for April-December, 2014. Consolidated NOCFPS was Tk. 12.59 for April-December, 2015 as against Tk. 7.75 for April-December, 2014. Consolidated NAV per share was Tk. 56.86 as of December 31, 2015 and Tk. 49.86 as of March 31, 2015.

SQURPHARMA 25-Jan-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2016 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on December 31, 2015.

Previous Next page